BIO-key International (BKYI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Aug, 2026Executive summary
The annual meeting is scheduled for September 3, 2026, at the company's headquarters, with four proposals on the agenda, including a new proposal regarding warrant issuance.
Stockholders of record as of July 15, 2026, are entitled to vote, and a revised proxy card is required to vote on all four proposals.
The company encourages all shareholders to submit a new proxy to ensure their votes are counted for the new proposal.
Voting matters and shareholder proposals
Proposal 1: Election of five directors to serve until the 2027 annual meeting.
Proposal 2: Ratification of M & K CPAs, PLLC as the independent auditor for 2026.
Proposal 3: Advisory approval of executive compensation.
Proposal 4: Approval of issuance of up to 1,236,668 shares upon exercise of new warrants from the August 10, 2026 inducement transaction.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Five nominees are listed for election to the board: Michael W. DePasquale, Wong Kwok Fong (Kelvin), Robert J. Michel, Cameron E. Willians, and Emanuel Alia.
Michael W. DePasquale serves as Chairman of the Board.
Latest events from BIO-key International
- Q2 2026 revenue up 13%, net loss down 51%, with record margin and EMEA-driven growth.BKYI
Q2 2026 - Biometric IAM solutions see rapid growth, regulatory tailwinds, and a path to profitability in 2026.BKYI
Investor presentation - Proxy covers director elections, auditor change, executive pay, and governance practices.BKYI
Proxy filing - Biometric authentication growth accelerates amid regulatory demand and sustained profitability.BKYI
RedChip Future Tech Investor Conference - Q1 revenue up 34% to $2.15M; profitability and Nasdaq relisting remain key near-term issues.BKYI
Q1 2026 - 2025 revenue fell 12%, but strong Q1 2026 outlook and sector wins support 2026 growth.BKYI
Q4 2025 - Vote proposed on a reverse stock split to regain Nasdaq compliance and enhance stock value.BKYI
Proxy Filing - Vote on a reverse stock split to regain Nasdaq compliance and enhance stock marketability.BKYI
Proxy Filing - Q1 2025 saw sequential revenue growth, margin strength, and improved cash, but liquidity risks remain.BKYI
Q1 2025